SCHEMBL4640112

SCHEMBL4640112

O=C(N[C@@H](Cn1cnc2c(N3CCC(C(=O)NC4=NCCCN4)CC3)ncnc21)C(=O)O)OCC12CC3CC(CC(C3)C1)C2

nearest known ligand 0.51

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 15/20 0.51
ITGAV P06756 15/20 0.51
ITGA2B P08514 7/20 0.51
STAT3 P40763 1/20 0.32
KMT2A Q03164 2/20 0.31
MEN1 O00255 1/20 0.31
MAPT P10636 1/20 0.31
ITGB5 P18084 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6805791 0.92 ITGB3 (0.44) ITGB3ITGAVITGA2BKMT2AMAPT
SCHEMBL4640085 0.86 ITGAV (0.38) ITGB3ITGAVITGA2BSTAT3MAPT
SCHEMBL6803682 0.86 ITGB3 (0.45) ITGB3ITGAVITGA2BKMT2AMEN1
SCHEMBL4640251 0.86 ITGB3 (0.49) ITGB3ITGAVITGA2BITGB5
SCHEMBL6806684 0.85 ITGB3 (0.41) ITGB3ITGAVITGA2BSTAT3KMT2A
SCHEMBL6805793 0.82 ITGB3 (0.41) ITGB3ITGAVITGA2BKMT2AMAPT
SCHEMBL4640102 0.81 ITGB3 (0.34) ITGB3ITGAVITGA2BSTAT3KMT2A
Benzene SCHEMBL6884463 0.81 ITGB3 (0.40) ITGB3ITGAVITGA2BSTAT3KMT2A
SCHEMBL4641013 0.80 ITGB3 (0.34) ITGB3ITGAVITGA2BSTAT3KMT2A
SCHEMBL4641339 0.80 STAT3 (0.38) ITGB3ITGAVSTAT3KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0853084-B1 Substituted purine derivatives as vitronectin receptor antagonists HOECHST AG (DE) 2008-08-13 EP disclosed
US-6723727-B1 VITRONECTIN RECEPTOR ANTAGONISTS; INHIBITORS OF BONE RESORPTION; OSTEOPOROSIS HOECHST AKTIENGESELLSCHAFT (DE) 2004-04-20 US disclosed
EP-0853084-A2 Substituted purine derivatives as vitronectin receptor antagonists HOECHST AKTIENGESELLSCHAFT (DE) 1998-07-15 EP disclosed